Brooks Laboratories Ltd. (BROOKS): Brooks Laboratories Share Price rises 8.56% as stock trades at Rs 69.01

Brooks Laboratories Share Price is trading at Rs 69.01, up 8.56% from the previous close of Rs 63.57, with market capitalisation at Rs 187.47 Cr. The move puts BROOKS in focus in today’s Share Market Today session and makes the stock a notable part of Stocks in News. The latest Univest figures confirm the price rise, while they do not establish a company-specific catalyst. For investors, the immediate read-through is straightforward: the stock is attracting attention because the price action is firm and the valuation can now be assessed against the healthcare peer set and company fundamentals.

Brooks Laboratories Share Price today also matters because the stock is trading near the day’s high of Rs 69.01 after opening at Rs 66.00 and touching a low of Rs 63.14. Turnover stood at Rs 0.03 Cr. In this kind of move, Univest focuses on what changed in price, how the company is valued and how it compares with the broader Indian stock market context.

Brooks Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 69.01
Previous Close	Rs 63.57
Today's Move	Rs 5.44 (+8.56%)
Open	Rs 66
High	Rs 69.01
Low	Rs 63.14
Turnover	Rs 0.03 crore
Market Capitalisation	Rs 187.47 crore
Market Cap Category	Micro Cap

Brooks Laboratories Ltd. (BROOKS) rose to Rs 69.01 from the previous close of Rs 63.57, a move of Rs 5.44 or 8.56%. The stock opened at Rs 66, reached a high of Rs 69.01, recorded a low of Rs 63.14.

Brooks Laboratories Share Price today moved higher by Rs 5.44, or 8.56%, with the stock last traded at Rs 69.01. The price also matched the day’s high of Rs 69.01, which shows that the share price rise held through the latest update. The previous close was Rs 63.57, so the gap between the prior session and the current trade is clearly visible in today’s stock news.

The move is best read as a price rise within the broader BROOKS Share Price Today narrative rather than as a confirmed event trigger. Since no company-specific catalyst is established in the latest Univest data, the cleanest interpretation is that the market has re-rated the stock in intraday trade while keeping it in the list of top movers under Stocks Rising Today.

Brooks Laboratories Ltd. (BROOKS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 187.47 crore
P/E Ratio	14.17x
P/B Ratio	1.51x
ROE	22.27%
ROCE	21.72%
EPS	Rs 4.49
Book Value Per Share	Rs 42.12
Dividend Yield	0%

Brooks Laboratories Ltd. (BROOKS) fundamental metrics show P/E 14.17x, P/B 1.51x, ROE 22.27%, ROCE 21.72%. These figures provide context only and are not a buy or sell signal.

Brooks Laboratories Ltd. has a market capitalisation of Rs 187.47 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 14.17x, P/B at 1.51x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.27% and ROCE of 21.72%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.49, book value per share of Rs 42.12, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.83%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	14.17x
Benchmark Median P/E	32.73x
Benchmark Average P/E	49.1x
Benchmark P/E Range	3.4x to 701.57x
Company P/B Ratio	1.51x
Benchmark Median P/B	3.06x
Company ROE	22.27%
Benchmark Median ROE	11.83%
Company ROCE	21.72%
Benchmark Median ROCE	13.68%
Company Market Capitalisation	Rs 187.47 crore
Benchmark Median Market Cap	Rs 750.93 crore

Brooks Laboratories Ltd. (BROOKS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Brooks Laboratories Ltd. (BROOKS) has a P/E ratio of 14.17x, which is below the benchmark median of 32.73x, a difference of -56.71%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Brooks Laboratories Ltd. (BROOKS) has a ROE of 22.27%, which is above the benchmark median of 11.83%, a difference of +88.25%. Brooks Laboratories Ltd. (BROOKS) has a ROCE of 21.72%, which is above the benchmark median of 13.68%, a difference of +58.77%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,48,315.74	36.98	5.17	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,51,737.22	85.36	14.14	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,87,593.62	85.95	20.89	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,12,618.18	24.71	4.14	19.69	21.39
Cipla Ltd.	CIPLA	1,10,515.04	33.08	3.17	11.83	16

Brooks Laboratories Ltd. (BROOKS) has a P/E ratio of 14.17x compared with the displayed peer median of 36.98x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.27% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.72% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Brooks Laboratories Ltd. (BROOKS) has a market capitalisation of Rs 187.47 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Brooks Laboratories

• Brooks Laboratories Share Price is rising today by 8.56%, keeping BROOKS in focus among Stocks in News.
• The stock is last traded at Rs 69.01, which is also the day’s high, so price action remains firm.
• Brooks Laboratories Share Price today is supported by ROE of 22.27% and ROCE of 21.72%.
• The P/E of 14.17 and P/B of 1.51 sit below the same-industry benchmark median.
• Brooks Laboratories Share Price news is being tracked because the stock’s valuation and peer positioning can be compared cleanly with the pharma set on Univest.

About Brooks Laboratories

Brooks Laboratories Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is tracked on both NSE and BSE under the BROOKS symbol, and investors often review Brooks Laboratories Share Price alongside company fundamentals, market capitalisation and industry positioning. Its business is linked to pharmaceutical operations, which places it in a segment where valuation, profitability and peer comparison are closely watched.

For readers following Brooks Laboratories Stock News, the company’s profile is best understood through its current market cap of Rs 187.47 Cr, its P/E ratio of 14.17, and operating returns that are above the benchmark median. That combination helps explain why Brooks Laboratories Share Price can draw attention even on a single trading day. Univest presents this as part of a broader view of the company overview, company financials and stock performance.

Frequently Asked Questions

Why is Brooks Laboratories Share Price rising today?

Ans. Brooks Laboratories Share Price is up 8.56% today to Rs 69.01. The latest Univest data confirms the price rise, but it does not establish a company-specific catalyst behind the move.

What is Brooks Laboratories Share Price today?

Ans. Brooks Laboratories Share Price today is Rs 69.01. It is trading above the previous close of Rs 63.57 and has moved up by Rs 5.44 in the current market update.

What is the market capitalisation of Brooks Laboratories?

Ans. Brooks Laboratories has a market capitalisation of Rs 187.47 Cr. That places it in a small-cap range and helps investors compare Brooks Laboratories Share Price with other healthcare names.

How does Brooks Laboratories compare on valuation?

Ans. Brooks Laboratories trades at a P/E of 14.17 and a P/B of 1.51. Both are below the same-industry median benchmark, which keeps Brooks Laboratories Share Price relatively modest versus many pharma peers.

What do Brooks Laboratories ROE and ROCE show?

Ans. Brooks Laboratories reports ROE of 22.27% and ROCE of 21.72%. Those figures are above the industry median benchmark and suggest the business is generating strong returns on equity and capital.

What are the EPS and book value for Brooks Laboratories?

Ans. EPS is Rs 4.49 and book value is Rs 42.12. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share in Brooks Laboratories Share Price analysis.

Does Brooks Laboratories pay a dividend?

Ans. Brooks Laboratories has a dividend yield of 0%. That means the latest dividend profile does not add yield support to the current Brooks Laboratories Share Price, so investors may focus more on valuation and operating returns.

How does Brooks Laboratories look versus pharma peers?

Ans. Brooks Laboratories trades at a lower P/E than listed peers such as Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals. Its market cap is far smaller, but its return ratios remain competitive in the healthcare peer set.

Track Brooks Laboratories Share Price on Univest

Use Brooks Laboratories Ltd. (BROOKS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Brooks Laboratories Share Price on Univest for live updates, valuation ratios, company financials, market cap, sector context, peer comparison and the latest stock news. Univest also helps readers follow Brooks Laboratories Share Price Today, Brooks Laboratories Stock Analysis and Brooks Laboratories Latest News in one place.

For those scanning the Indian stock market for market movers, Univest keeps the Brooks Laboratories Share Price story connected to the broader Market Update, so the latest move can be read with fundamentals and sector context rather than in isolation.